Correlation Between Black Diamond and Invivyd

Can any of the company-specific risk be diversified away by investing in both Black Diamond and Invivyd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Invivyd into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Black Diamond Therapeutics and Invivyd, you can compare the effects of market volatilities on Black Diamond and Invivyd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Invivyd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Invivyd.

Diversification Opportunities for Black Diamond and Invivyd

0.37

Correlation Coefficient

Black Diamond  Invivyd

Weak diversification

The 3 months correlation between Black and Invivyd is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Invivyd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invivyd and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Invivyd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invivyd has no effect on the direction of Black Diamond i.e., Black Diamond and Invivyd go up and down completely randomly.

Pair Corralation between Black Diamond and Invivyd

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Invivyd. But the stock apears to be less risky and, when comparing its historical volatility, Black Diamond Therapeutics is 1.47 times less risky than Invivyd. The stock trades about -0.28 of its potential returns per unit of risk. The Invivyd is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  85.00  in Invivyd on August 30, 2024 and sell it today you would lose (17.60) from holding Invivyd or give up 20.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Black Diamond Therapeutics  vs.  Invivyd

Black Diamond Therap

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Invivyd

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Invivyd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Black Diamond and Invivyd

The main advantage of trading using opposite Black Diamond and Invivyd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Invivyd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invivyd will offset losses from the drop in Invivyd's long position.

The idea behind Black Diamond Therapeutics and Invivyd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.